𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of IgA class antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease (IBD)

✍ Scribed by Hans-Jacob Haga; Øyvind Palm; Elisabeth Peen

Publisher
Springer
Year
2011
Tongue
English
Weight
74 KB
Volume
30
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of early treatment in inflammato
Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
✍ Tracey M. Farragher; Mark Lunt; Darren Plant; Diane K. Bunn; Anne Barton; Debora 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 107 KB 👁 2 views

## Abstract ## Objective To compare the clinical utility of anti–cyclic citrullinated peptide (anti‐CCP) antibodies and rheumatoid factor (RF) testing in predicting both functional outcome and response to treatment in early inflammatory polyarthritis (IP) patients. ## Methods A total of 916 IP s

Absence of antibodies to cyclic citrulli
Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia
✍ Mark H. Wener; Kathleen Hutchinson; Chihiro Morishima; David R. Gretch 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

## Abstract ## Objective To determine if antibodies to cyclic citrullinated peptide (anti‐CCP) are found in chronic hepatitis C virus (HCV) infection. ## Methods Rheumatoid factor (RF) and anti‐CCP were measured in sera from 50 patients with HCV infection but without cryoglobulinemia, sera from